Stay updated on Nivolumab in Pediatric Hypermutant Cancers Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in Pediatric Hypermutant Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in Pediatric Hypermutant Cancers Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.3 to v3.5.4, indicating an updated version of the page/document. This change is metadata-level and does not alter the study details or content on the page.
    Difference
    0.1%
    Check dated 2026-05-15T05:55:21.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    A minor user-interface/version update changes the displayed site revision from v3.5.2 to v3.5.3 without altering the study details.
    Difference
    0.1%
    Check dated 2026-04-24T06:19:22.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:46:50.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0. This appears to be a minor version bump with no changes to study content or functionality visible to users.
    Difference
    0.1%
    Check dated 2026-03-19T06:12:26.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Revision: v3.4.3 added and v3.4.2 removed; this reflects a site version update rather than changes to study information.
    Difference
    0.1%
    Check dated 2026-03-12T00:00:53.000Z thumbnail image
  8. Check
    94 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is now displayed; the page shows the new revision and removes the earlier v3.4.1 notice. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T14:16:56.000Z thumbnail image

Stay in the know with updates to Nivolumab in Pediatric Hypermutant Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in Pediatric Hypermutant Cancers Clinical Trial page.